Re: ZEN-3694 Single Agent Trial Status
in response to
by
posted on
Sep 19, 2017 07:56AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
To continue the speculation game, I say a deal for both.